Biocryst Pharmaceuticals buy HC Wainwright

Summary

This prediction ended on 07.05.26 with a price of €7.45. The price of Biocryst Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.76%. HC_Wainwright has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. HC_Wainwright has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Biocryst Pharmaceuticals	-2.886%	-2.886%	11.219%
iShares Core DAX®	2,59 %	2,69 %	6,41 %
iShares Nasdaq 100	-0,91 %	-7,37 %	20,65 %
iShares Nikkei 225®	0,15 %	-10,20 %	46,17 %
iShares S&P 500	-0,37 %	-0,83 %	18,02 %